Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -528,805 | -240,922 | -127,190 | -63,534 | -10,066 |
| Depreciation Amortization | 646 | 4,349 | N/A | N/A | N/A |
| Income taxes - deferred | N/A | N/A | 9 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,319 | 5,390 | 3,975 | 678 | 23 |
| Other Working Capital | 40,968 | 6,791 | 583 | 2,834 | -261 |
| Other Operating Activity | 106,541 | 27,251 | 27,808 | 30,518 | 4,679 |
| Operating Cash Flow | $-377,331 | $-197,141 | $-94,815 | $-29,504 | $-5,625 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,784 | -4,165 | -541 | -26 | -3 |
| Purchase Of Investment | 0 | -6,375 | -6,627 | -3,000 | N/A |
| Investing Cash Flow | $-3,784 | $-10,540 | $-7,168 | $-3,026 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | 5,000 | N/A |
| Debt Repayment | -1,150 | N/A | -5,595 | N/A | N/A |
| Common Stock Issued | 310,743 | 237,402 | 180,422 | 11,399 | 4,853 |
| Other Financing Activity | 125,000 | 103,060 | 34,932 | 38,363 | 463 |
| Financing Cash Flow | $434,593 | $340,462 | $209,759 | $54,762 | $5,316 |
| Beginning Cash Position | 264,249 | 131,468 | 23,692 | 1,460 | 1,772 |
| End Cash Position | 317,727 | 264,249 | 131,468 | 23,692 | 1,460 |
| Net Cash Flow | $53,478 | $132,781 | $107,776 | $22,232 | $-312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -377,331 | -197,141 | -94,815 | -29,504 | -5,625 |
| Capital Expenditure | -3,784 | -4,165 | -541 | -26 | -3 |
| Free Cash Flow | -381,115 | -201,306 | -95,356 | -29,530 | -5,628 |